Novonesis Delivered 8% Organic Sales Growth In The First Nine Months Of 2025
Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. 10 November
Read More
Novonesis
Deal to Acquire dsm-firmenich’s Share Of The Feed Enzyme Alliance Is Completed, Supporting Novonesis’ Growth Strategy
05 June 2025, Denmark: The acquisition is part of Novonesis’ growth strategy and expands its presence across the animal biosolutions value chain.
Read More
Novonesis To Capture Fast-growing Market For Protein-rich Products With Vertera Plant-based Biosolutions
21 May 2025, Denmark: A year ago, Novozymes and Chr. Hansen became Novonesis. The company is reaping the benefits of the combination
Read More
Combining EVP roles of Human Health Biosolutions and Strategy & Integration
21 May 2025, Denmark: As a next step on Novonesis’ integration journey, we combine EVP areas Human Health Biosolutions and Strategy &
Read More
Novonesis Delivers Strong Full-year Results And Expects Continued Growth In 2025
26 February 2025, Denmark: In the 2024 financial year, Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin at 36.1%.
Read More
KRIBHCO and Novonesis Join Hands to Bring Biological Solution to Indian Farmers
16 September 2024, New Delhi: Krishak Bharati Cooperative Limited (KRIBHCO) and Novonesis signed an MoU announcing a long-term commitment to explore collaboration
Read More